DELAWARE BIO

FEDERAL POLICY

Delaware Bio accelerates mutually beneficial relationships with the federal delegation in Washington, D.C.

DELAWARE BIO REGULARLY COMMUNICATES WITH DELAWARE'S SENATORS AND CONGRESSWOMAN ON THE FEDERAL POLICY ISSUES THAT RELATE TO OUR INDUSTRY.

EXAMPLES INCLUDE:

EDUCATING ON THE VALUE OF BIOMEDICAL INNOVATION

Which improves quality of life, limits costs to the healthcare system, and gives patients time to live fuller lives

THE PRESERVATION OF THE CURRENT VERSION OF MEDICARE PARTS B & D

Which allow for lower costs for the Medicare program as well as better outcomes for the beneficiaries

THE CONTINUED FUNDING OF THE NATIONAL INSTITUTES OF HEALTH (NIH)

Which is important for groundbreaking medical research

THE CONTINUED FUNDING OF THE FOOD AND DRUG ADMINISTRATION (FDA)

To quicken the approval process so life-saving treatments reach patients. The FDA also contributes to food safety

PROGRESS IN THE RENEWABLE FUEL STANDARD

To ensure America’s path towards energy independence, is important to many companies in our state, as well as institutions conducting research like the University of Delaware and Delaware State University

ENCOURAGING A NATIONWIDE STANDARD FOR LABELING OF FOODS

With genetically modified ingredients (GMOs), as an alternative to expensive and complex state-by-state laws

STRENGTHENING PROTECTION OF CORPORATE TRADE SECRETS AND REFORMING THE INTELLECTUAL PROPERTY (PATENT LAW) SYSTEM

Both of which are crucial to innovative discoveries – the lifeblood of our industry – reaching the marketplace

GET SOCIAL WITH US!  #DEBIO